Dr. C A. Schroeder, M.D.
Pulmonology (Pulmonary Disease Physician)
9401 Wilshire Blvd, Suite 515
Beverly Hills, CA 90212
Who else practices at this address →
Los Angeles County includes primary care (7% of residents) and mental health (13% of residents) shortage areas. About shortage areas
Medicare and federal program status
Opted out of Medicare from February 1, 2019 through February 1, 2027. Medicare does not pay for this clinician’s services: patients with Medicare sign a private contract and pay the clinician directly. They can still order tests and refer Medicare patients to other providers.
Source: CMS Medicare Opt Out Affidavits (record last updated October 21, 2026). Opting out is a legal choice many clinicians make, often to run a cash or concierge practice.
At a glance
- In the NPI registry since
- 2006
Licensed in California since 2001, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pulmonary Disease Physician primary
CA license A74826 (first issued 2001; current) -
Critical Care Medicine (Internal Medicine) Physician
CA license A74826 (first issued 2001; current)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Levothyroxine Sodium Other prescribers in Beverly Hills, CA | 72 |
| Metformin Hcl Other prescribers in Beverly Hills, CA | 52 |
| Rosuvastatin Calcium Other prescribers in Beverly Hills, CA | 51 |
| Breo Ellipta (fluticasone/vilanterol) Other prescribers in Beverly Hills, CA | 42 |
| Mounjaro (tirzepatide) Other prescribers in Beverly Hills, CA | 38 |
| Losartan Potassium Other prescribers in Beverly Hills, CA | 34 |
| Azithromycin Other prescribers in Beverly Hills, CA | 34 |
| Synthroid (levothyroxine sodium) Other prescribers in Beverly Hills, CA | 32 |
| Amlodipine Besylate Other prescribers in Beverly Hills, CA | 31 |
| Lorazepam Other prescribers in Beverly Hills, CA | 28 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 16 companies reported 51 payments worth $1,203 in total to this clinician.
| Janssen Biotech, Inc. | $218 |
|---|---|
| AbbVie Inc. | $199 |
| Aimmune Therapeutics, Inc. | $179 |
| Lilly USA, LLC | $155 |
| GlaxoSmithKline, LLC. | $76.82 |
| Takeda Pharmaceuticals U.S.A., Inc. | $57.44 |
| Alnylam Pharmaceuticals Inc. | $53.40 |
| Phathom Pharmaceuticals, Inc. | $42.86 |
| Food and Beverage | $1,203 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $17,361 in research payments for these studies, mostly to the institutions running them.
- Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD)
Sanofi US Services Inc. · Completed · NCT04701983 - A 52-week, randomised, double-blind, double-dummy, parallel group, mul
GlaxoSmithKline, LLC.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.